Helix BioPharma Announces Fiscal 2026 Year-End Results
Helix BioPharma announced financial results for fiscal 2026; the supplied text does not include the figures.
Related stories
Exxon, Chevron report profit surge amid refinery boom
A German-language headline reports a profit surge at Exxon and Chevron, attributing it to a war-related refinery boom. It gives no figures or reporting period.
M impact | EARNINGS | Oct 30, 2026, 03:03 PM UTC
General Dynamics Raises Annual Forecast on Strong Gulfstream, Naval Orders
General Dynamics raised its annual forecasts, citing strong orders for Gulfstream and its naval business.
M impact | EARNINGS | Oct 30, 2026, 02:55 PM UTC
Imperial Oil earnings above expectations at 5.11 CAD
Imperial Oil (IMO) released earnings per share at 5.11 CAD, compared to market expectations of 4.03 CAD.
H impact | EARNINGS | Oct 30, 2026, 02:47 PM UTC
Canadian National Railway earnings above expectations at 2.16 CAD
Canadian National Railway (CNR) released earnings per share at 2.16 CAD, compared to market expectations of 2.02 CAD.
H impact | EARNINGS | Oct 30, 2026, 02:47 PM UTC
Syngenta Group Revenue Falls as Heatwave Hurts Sales
Syngenta said a European summer heatwave reduced demand for its crop-protection products, while cash-strapped farmers bought fewer new seeds.
M impact | EARNINGS | Oct 30, 2026, 02:45 PM UTC
Illumina Falls After Missing Third-Quarter Revenue Targets
Illumina shares fell after the company missed its third-quarter revenue targets.
M impact | EARNINGS | Oct 30, 2026, 02:44 PM UTC